CAST A WIDER NET
WITH BIOCHEMICAL
PRENATAL SCREENING

Read the Contemporary OB/GYN Supplement Now

Patients

The early weeks of pregnancy can be an exciting, but anxious time. Like many expectant mothers, you may want to know the facts about your baby’s risk for chromosomal abnormalities.
More »

Health Care Providers

For years, leading ObGyns and maternal fetal medicine specialists have recognized NTD as the innovator in prenatal screening for open neural tube defects and Down syndrome.
More »

Early Onset Preeclampsia

The sooner you know your risk for preeclampsia, the better. Patients and their physicians now have a first-of-its-kind blood test to screen for early onset preeclampsia during the first trimester.
More »


We are proud to announce that NTD Labs is now a part of the Eurofins laboratory network. Eurofins, a worldwide leader in its field, is uniquely positioned to meet the expanding needs of NTD's customers and provides opportunity for NTD to offer new and innovative prenatal screening solutions for you and your patients. Please click here to learn more.

You can continue to count on service and support from the same NTD contacts that you currently have. In the coming months, we will keep you informed of our progress as the integration process evolves. A dedicated team from across our organization will ensure a seamless transition. We are fully committed to maintaining clinical excellence and strong customer relationships throughout the integration and continuing to provide you with the high level of service and rapid turnaround time for your patient's sample results that you expect from NTD.

(References 13, 25, 36)



DISCLAIMER: Pursuant to applicable federal and/or state laboratory requirements, NTD has established and verified the accuracy and precision of its testing services. Tests are developed and performance characteristics determined by NTD. The methods and performance characteristics have been reviewed and approved by the New York State Department of Health.